Lisata Therapeutics Statistics
Total Valuation
LSTA has a market cap or net worth of $23.47 million. The enterprise value is -$2.27 million.
Important Dates
The next estimated earnings date is Monday, August 11, 2025, after market close.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LSTA has 8.60 million shares outstanding. The number of shares has increased by 3.14% in one year.
| Current Share Class | 8.60M |
| Shares Outstanding | 8.60M |
| Shares Change (YoY) | +3.14% |
| Shares Change (QoQ) | +2.47% |
| Owned by Insiders (%) | 17.40% |
| Owned by Institutions (%) | 9.11% |
| Float | 7.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.43 |
| Forward PS | n/a |
| PB Ratio | 0.83 |
| P/TBV Ratio | 0.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.52, with a Debt / Equity ratio of 0.00.
| Current Ratio | 7.52 |
| Quick Ratio | 6.98 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -56.92% and return on invested capital (ROIC) is -39.69%.
| Return on Equity (ROE) | -56.92% |
| Return on Assets (ROA) | -35.05% |
| Return on Invested Capital (ROIC) | -39.69% |
| Return on Capital Employed (ROCE) | -86.02% |
| Revenue Per Employee | $38,462 |
| Profits Per Employee | -$742,615 |
| Employee Count | 26 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -962,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.94% in the last 52 weeks. The beta is 1.00, so LSTA's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | -19.94% |
| 50-Day Moving Average | 2.48 |
| 200-Day Moving Average | 2.68 |
| Relative Strength Index (RSI) | 59.62 |
| Average Volume (20 Days) | 14,537 |
Short Selling Information
The latest short interest is 30,815, so 0.36% of the outstanding shares have been sold short.
| Short Interest | 30,815 |
| Short Previous Month | 28,381 |
| Short % of Shares Out | 0.36% |
| Short % of Float | 0.43% |
| Short Ratio (days to cover) | 2.06 |
Income Statement
In the last 12 months, LSTA had revenue of $1.00 million and -$19.31 million in losses. Loss per share was -$2.30.
| Revenue | 1.00M |
| Gross Profit | 1.00M |
| Operating Income | -21.66M |
| Pretax Income | -23.18M |
| Net Income | -19.31M |
| EBITDA | -21.48M |
| EBIT | -21.66M |
| Loss Per Share | -$2.30 |
Full Income StatementBalance Sheet
The company has $25.83 million in cash and $92,000 in debt, giving a net cash position of $25.74 million or $2.99 per share.
| Cash & Cash Equivalents | 25.83M |
| Total Debt | 92,000 |
| Net Cash | 25.74M |
| Net Cash Per Share | $2.99 |
| Equity (Book Value) | 25.10M |
| Book Value Per Share | 2.94 |
| Working Capital | 24.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$17.73 million and capital expenditures -$28,000, giving a free cash flow of -$17.76 million.
| Operating Cash Flow | -17.73M |
| Capital Expenditures | -28,000 |
| Free Cash Flow | -17.76M |
| FCF Per Share | -$2.07 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -2,165.50% |
| Pretax Margin | -2,027.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LSTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.14% |
| Shareholder Yield | -3.14% |
| Earnings Yield | -82.26% |
| FCF Yield | -75.66% |
Analyst Forecast
The average price target for LSTA is $15.00, which is 449.45% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 449.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 115.91% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 15, 2022. It was a reverse split with a ratio of 0.0666667:1.
| Last Split Date | Sep 15, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0666667:1 |
Scores
LSTA has an Altman Z-Score of -24.31 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -24.31 |
| Piotroski F-Score | 1 |
